Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00176839 Background | Jun 2000 → Feb 2012 | acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndrome | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00176839 ↗ |
| Route | Intravenous | “daily IV” NCT00176839 ↗ |